Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Aemetis Biogas Receives $11 Million From Sale of IRA Investment Tax Credits
-
The Breast Cancer Research Foundation Backs Clairity's AI-Based Risk Assessment
-
KFSHRC Modernizes Biobank Center… Ushering an Era of Personalized Medicine
-
AI Unlimited Group Unveils Next-Generation AI Model Collaboration Testing with Groq Cloud
-
Invesco Ltd: Form 8.3 - International Paper Co; Public dealing disclosure
-
Sony Electronics and Media RED Join Forces to Elevate Retail Media Through Innovative Display Technology Activations
-
High Roller Technologies Provides Business Update with Key Milestones
-
Barksdale Announces Replacement Convertible Debentures
-
Rigel Provides Business Update and 2025 Outlook
-
Harmony Biosciences Reports Strong 2024 Revenues, Provides 2025 Revenue Guidance and Highlights Key Pipeline Catalysts
-
Safe-Pro USA to Feature its Advanced, High-Performance, Ultra-Lightweight “305 PRO” Body Armor Plate for Law Enforcement at the 2025 SHOT Show
-
Butterfly Network and Rutgers Robert Wood Johnson Medical School Reveal Preliminary Findings from Seminal Study on Impact of POCUS in Hospital Care
-
IonQ Announces New $21.1 Million Project with United States Air Force Research Lab (AFRL) to Push Boundaries on Secure Quantum Networking
-
LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™
-
ORIC® Pharmaceuticals Provides Early Phase 1b Combination Data for ORIC-944, Operational Highlights for 2024, and Anticipated Upcoming Milestones
-
StepStone Group Closes Inaugural Infrastructure Co-investment Fund, Surpassing $1 billion
-
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces it has Filed an Application with NASDAQ to Uplist to the NASDAQ Global Market from the NASDAQ Capital Market
-
Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities
-
Armani Group Elevates Global E-commerce and Unifies Online and Offline Stores with XY OMS Rollout Across 40+ Countries
-
Phyllo Wins SmartBear’s Developer Visibility Award for Excellence in Collaboration and Innovation
-
RewardOps Predicts that Consumers Will Look for Personal Value in Loyalty Programs in 2025
-
Welles Enhances Customer Engagement & Operational Efficiency With Seek AI Agents
-
Bridger Aerospace Confirms the Mobilization of Super Scooper Aircraft to California to Assist in Firefighting Efforts
-
Resource Label Group Acquires Screenprint/Dow’s Label Business
-
Catheter Precision, Inc. Announces Initial LockeT Purchase From the University of Tennessee Medical Center
-
American Resources Corporation's ReElement Technologies and LVC Global Holdings Launch "ReElement Middle East" to Advance Critical Minerals Processing in the Region
-
1606 Corp. Applauds Adnexus Biotechnologies' Launch of Trapicolast: A Revolutionary New AI-Driven Malaria Drug
-
Gorilla Addresses Market Misinformation and Announces Increase to Share Buyback Programme
-
Adcore Starts 2025 Off Strong With Robust Financial Position & Media Blast Performance Update
-
Xcyte Digital Introduces PRISM Marketplace: An Immersive Venue for Investors and Small Cap Companies
-
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
-
Clear Start Tax Provides a Comprehensive Guide to Help Taxpayers Qualify for the IRS Fresh Start Program in 2025
-
KWG Resources Inc Is Honoured to Be Selected as a Member of the USA Defense Industrial Base Consortium
-
Walkbase Unveils Game-Changing Millimeter Wave Sensor Solution at NRF
-
C-COM Announces Suspension of Quarterly Dividends to Prioritize Strategic Investments
-
Telescope Innovations Demonstrates Production of >99% Pure Lithium Carbonate from Widely Varied North American Brines
-
WSP to Launch 2025-2027 Global Strategic Action Plan and Host Investor Day
-
Porsche Cars Canada reports its sales results for 2024
-
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Report Positive Topline Data from 8 mg Dose of Phase 2 Obesity Trial of GLP-1/GIP Receptor Dual Agonist HRS9531
-
Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology
-
Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics
-
Augmedix Awarded Vizient Contract for Ambient AI Documentation Solutions
-
Equinix Announces Tax Treatment of 2024 Distributions
-
Honeywell and Verizon Launch Groundbreaking Solution to Streamline Retail Lifecycle from Procurement through Customer Operations
-
Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors
-
Float Financial Announces $70 Million Investment Round Led by Growth Equity at Goldman Sachs Alternatives to Build Canada’s Most Complete Business Finance Solution
-
BitMine Reports Fiscal 1st Quarter 2025 Financial Results
-
Veradigm Adds Social Determinants of Health and Mortality Data to EHR Database to Allow Deeper Insights into the Patient Journey
-
Ashvattha Therapeutics Announces $50 Million Financing Extension and Interim Phase 2 Ophthalmology Trial Results
-
Candel Therapeutics Provides Corporate Update and Highlights Strong Pipeline Momentum and Key Value Drivers for 2025
